Advertisement
Canada markets open in 2 hours 46 minutes
  • S&P/TSX

    24,102.71
    -60.12 (-0.25%)
     
  • S&P 500

    5,695.94
    -55.13 (-0.96%)
     
  • DOW

    41,954.24
    -398.51 (-0.94%)
     
  • CAD/USD

    0.7329
    -0.0013 (-0.18%)
     
  • CRUDE OIL

    75.53
    -1.61 (-2.09%)
     
  • Bitcoin CAD

    85,153.77
    -752.84 (-0.88%)
     
  • XRP CAD

    0.72
    -0.00 (-0.48%)
     
  • GOLD FUTURES

    2,662.20
    -3.80 (-0.14%)
     
  • RUSSELL 2000

    2,193.09
    -19.71 (-0.89%)
     
  • 10-Yr Bond

    4.0260
    +0.0450 (+1.13%)
     
  • NASDAQ futures

    20,066.25
    +73.50 (+0.37%)
     
  • VOLATILITY

    22.13
    -0.51 (-2.25%)
     
  • FTSE

    8,213.80
    -89.82 (-1.08%)
     
  • NIKKEI 225

    38,937.54
    -395.20 (-1.00%)
     
  • CAD/EUR

    0.6670
    -0.0018 (-0.27%)
     

U.S. FDA approves Eisai, Biogen's Alzheimer's drug

Jan 6 (Reuters) - The U.S. Food and Drug Administration approved Eisai Co Ltd's and Biogen Inc's Alzheimer's drug lecanemab for patients in the earliest stages of the mind-wasting disease, the agency said on Friday. (Reporting by Deena Beasley in Los Angeles and Bhanvi Satija in Bengaluru; Editing by Bill Berkrot)